CXO has been producing Spod but the stock languishes nonetheless.
There is nothing magical about getting into production - not if the production is not sold at a decent margin to generate the desired FCF.
LTR getting into production - the only final catalyst hodlers hope that can enthused buyers, but it is most publicised and anticipated outcome for some time.
1 year view
CXO Stock Price and Chart — ASX:CXO — TradingView
The final spodumene shipment for FY24 of 10,413dmt left Darwin in mid-June.
During the June 2024 Quarter, Core sold:
• 33,027dmt of spodumene concentrate at a 4.8% grade; and • 19,771dmt of lithium fines at a1.3% grade.
In FY24, Core exceeded the revised FY24 guidance and sold 97,423dmt of spodumene concentrate at an average grade of 4.8%.
- Forums
- ASX - General
- EV/Lithium
CXO has been producing Spod but the stock languishes...
Featured News
Featured News
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online